General MedicationsVAGINALStandard
XACIATO
CLINDAMYCIN PHOSPHATE
Standard Dose
EQ 2% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview XACIATO is listed in Drugs@FDA under application 215650 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength GEL;VAGINAL - EQ 2% BASE Sponsor ORGANON LLC Submission history Latest submission status date: 2023-03-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview XACIATO is listed in Drugs@FDA under application 215650 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength GEL;VAGINAL - EQ 2% BASE Sponsor ORGANON LLC Submission history Latest submission status date: 2023-03-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.